X
BMS backs record $600m European venture fund closed by LSP
https://pharmaphorum.com/news/bms-backs-record-600m-european-venture-fund-closed-by-lsp/
European biotech
Acacia Pharma stock market launch to support nausea products
Acacia Pharma is to raise new funds through an initial global offering and launch on to the Euronext Brussels stock exchange
Takeda to buy stem cell specialists TiGenix for $626m
Decision follows EU regulators’ decision to back Crohn’s stem cell therapy
Boehringer collaborates with Autifony on schizophrenia drug
Deal could be worth 627.5 million euros
After more encouraging data, Ablynx to file first drug with FDA
New trial data will be included in US and EU filings
How can the UK improve in clinical research? A biotech perspective
The UK is a great place for early-stage research – but NHS red tape and market access remain major barriers.
1 2